about
Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in europeThe complex relationship between human immunodeficiency virus infection and death in adults being treated for tuberculosis in Cape Town, South AfricaPharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis.Drug-resistant tuberculosis transmission and resistance amplification within families.Standardized Methods for Enhanced Quality and Comparability of Tuberculous Meningitis Studies.Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.Paediatric use of second-line anti-tuberculosis agents: a review.Management of children exposed to multidrug-resistant Mycobacterium tuberculosis.High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study.A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.Childhood TB: can the End TB Strategy deliver?The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysisOutcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.Global burden of drug-resistant tuberculosis in children: a mathematical modelling study.Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.Reply to Raoult.HIV and tuberculosis in children: biology meets epidemiology.Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study.Trends in childhood drug-resistant tuberculosis in South Africa: a window into the wider epidemic?Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.Short intensified treatment in children with drug-susceptible tuberculous meningitis.Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.Hearing loss in children treated for multidrug-resistant tuberculosis.Retooling existing tuberculosis drugs for children.A retrospective analysis of paediatric tuberculosis diagnosis in London: room for improvement?Discordant drug susceptibility for mycobacterium tuberculosis within families.Multidrug-resistant tuberculosis of the spine in children--characteristics from a high burden setting.Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcome.Interrupted BCG vaccination is a major threat to global child health.The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.Cerebral and splanchnic hemodynamics after duct ligation in very low birth weight infants.Excellent Treatment Outcomes in Children Treated for Tuberculosis Under Routine Operational Conditions in Cape Town, South Africa.Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.If you look, you will find: time to challenge the childhood tuberculosis paradigm.Time to be a bit more 'surgical' in our management of children with drug-resistant tuberculosis.Effect of Co-Administration of Lidocaine on the Pain and Pharmacokinetics of Intramuscular Amikacin in Children with Multidrug-Resistant Tuberculosis: A Randomized Crossover Trial.Multidrug-resistant tuberculosis in children in northwest Russia: an observational cohort study.Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysisLevofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)
P50
Q33748685-9C78DCAC-7C49-4B19-966F-E84FA66FDB08Q35665530-D1835436-9139-4D71-AB07-47EBA716C3A2Q36075800-D20B7CBB-292E-4270-8EF0-CE620A047F85Q36148038-8416A2CF-9165-448C-89A5-D95057457A38Q36273077-FE2BB8E4-6ACE-44A2-9ADB-07853EB402DAQ37339294-67036D4C-0110-4DC1-915C-AD0C9ED2752DQ37961280-532BAFBD-1802-483F-90E1-278A09C58D28Q37988983-BB1754A7-914A-44B5-8BA0-85629BE36B87Q38142536-505D7315-7E75-43FF-99B6-229C5E6DB28AQ38582633-77F02B10-8D19-46CE-A5F5-A2A98A44A1B4Q38736697-1979AB0B-9D94-425D-98A1-8E0F0BA99E37Q39003366-16D1BEA5-9874-4108-BA22-65694752227BQ39253919-84BCF77A-FA79-465F-B535-4D95A1A81919Q39656363-5B28D345-5104-4856-8285-F83E24E3CEA9Q40113341-C2285AEF-ACCE-442A-A59D-C78EDA63624CQ40270386-E31D6C66-FC4C-42B6-9657-06A5DCCFC45EQ40891730-8A5CDC4A-E94E-40D5-8D55-F860512ADDA1Q42202733-62FD61F1-8AB9-43A3-B195-BBB80B59214CQ42211996-A4A136D6-E19A-4146-8CF4-2D802CD365D9Q42246655-A1810D2D-CE25-4649-A651-BAB4149213DBQ42813201-6E24A1B5-5EF5-4B9D-A329-DA892B41931EQ43200280-9A8E6FD7-BFD7-4A6E-AC0E-6837E992761EQ44020809-0F6A1E28-6099-4352-BD4E-0CC94689FAACQ44631374-D085636E-84C7-4701-9C24-FFE13B73BE76Q46139785-145EDCD9-5CCE-48FB-82E1-C270B8CBEE09Q46202628-161ED2B1-635A-4D01-BB9B-60C4634F2B14Q46240958-E8BBFA4D-20EF-4ADD-A63B-9297B42E3FC5Q46638483-20B90F2E-BC80-4024-994B-D4135D8980F0Q46650004-ECDAD05E-4EBA-41F3-B4FD-3D5187FF6A25Q46866838-151BA6AE-DA07-42EE-9AE9-A8F43948B9ABQ47215313-3E240BCD-96B5-4153-8DCB-B2BA641772C6Q47607508-2A8D56D5-1532-4041-8AB9-37409D2D5508Q47820645-67E43F1B-EC49-428B-9B4B-DB63B5B30D37Q50663861-6A521E1C-EDFC-4666-BD35-546DB5C87A45Q53515705-588258EB-2856-4708-9BD1-FEAE53BD680FQ53699787-C00E25C3-DCDD-4BB7-AE4F-0D98DB28F060Q53763048-EAFF6B01-F827-46A6-9128-257ECEE862C1Q53787948-613023E4-A7BD-45C5-B5B4-5B0F2D83C86FQ56889741-1AF94F85-8A36-467E-941C-638FA295964FQ60945458-AC7813C6-FED2-4A5A-9F49-5492D3D3FD7A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
James A Seddon
@ast
James A Seddon
@en
James A Seddon
@es
James A Seddon
@nl
James A Seddon
@sl
type
label
James A Seddon
@ast
James A Seddon
@en
James A Seddon
@es
James A Seddon
@nl
James A Seddon
@sl
prefLabel
James A Seddon
@ast
James A Seddon
@en
James A Seddon
@es
James A Seddon
@nl
James A Seddon
@sl
P106
P21
P31
P496
0000-0002-2296-2302